CIK 0001757499 · <br>Emerging growth company
Shuttle Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- SHPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (240) 403-4212
- Business address
- 401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD, 20879
- Former names
- Shuttle Pharmaceuticals Holdings, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 5/A Insider Annual Insider Trading Report
- 5/A Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Chief Scientific Officer acquired 598 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 1,626 shares at $1.61 ($2,610)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Open-market sale Director sold 2,921 shares at $0.46 ($1,353)
- 4 Open-market sale Director sold 4,157 shares at $0.46 ($1,926)
- 4 Gift CEO and Chairman gave 2,100,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale Former Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale Director sold 995 shares at $1.61 ($1,597)
- 4 Open-market sale CEO and Chairman sold 8,372 shares at $1.61 ($13,437)
- 4 Open-market sale Chief Medical Officer sold 1,414 shares at $1.61 ($2,269)
Page 2 of 3 · 56 filings